President Donald Trump on Tuesday introduced a $1.5 billion contract with US biotech firm Moderna for 100 million doses of an eventual coronavirus vaccine, the sixth such deal reached since May.
“I’m pleased to announce that we have reached an agreement with Moderna to manufacture and deliver 100 million doses of their coronavirus vaccine candidate,” Trump mentioned at a White House information convention. “The federal government will personal these vaccine doses, we’re shopping for them.”
“We’re on track to rapidly produce 100 million doses as soon as the vaccine is approved, and up to 500 million shortly thereafter, so we’ll have 600 million doses,” he added.
Moderna, in partnership with the US National Institutes of Health (NIH), is conducting Phase three medical trials of a vaccine candidate and manufacturing of vaccine doses will happen whereas the trials are underway.
The vaccine, referred to as mRNA-1273, is being co-developed by Moderna and the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), which is led by Dr. Anthony Fauci.
Fauci has mentioned researchers are unlikely to know the efficacy of the vaccine earlier than the top of the 12 months on the earliest. But Trump has mentioned he hopes to have a vaccine earlier than the November three presidential election.
The newest contract brings the US authorities’s whole commitments to Moderna to $2.48 billion.
The firm, based lower than 10 years in the past, has not beforehand developed a vaccine of any type however preliminary outcomes of the corporate’s experimental COVID-19 vaccine have reportedly produced promising outcomes.
The Trump administration has allotted a complete of no less than $10.9 billion for the event and manufacturing of a coronavirus vaccine.
It has already ordered 100 million vaccine doses from Johnson & Johnson, Novavax, Pfizer and Sanofi and 300 million from AstraZeneca.
© 2020 AFP
Trump announces sixth vaccine contract, for 100 mn doses (2020, August 12)
retrieved 12 August 2020
This doc is topic to copyright. Apart from any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.